Annual EBIT
-$252.10 M
-$116.23 M-85.54%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual earnings before interest & taxes is -$252.10 million, with the most recent change of -$116.23 million (-85.54%) on December 31, 2023.
- During the last 3 years, NMRA annual EBIT has fallen by -$156.58 million (-163.93%).
- NMRA annual EBIT is now -163.93% below its all-time high of -$95.52 million, reached on December 1, 2020.
Performance
NMRA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$76.65 M
-$12.82 M-20.09%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly earnings before interest & taxes is -$76.65 million, with the most recent change of -$12.82 million (-20.09%) on September 30, 2024.
- Over the past year, NMRA quarterly EBIT has dropped by -$16.57 million (-27.59%).
- NMRA quarterly EBIT is now -396.25% below its all-time high of -$15.45 million, reached on March 1, 2021.
Performance
NMRA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$314.55 M
-$19.78 M-6.71%
September 30, 2024
Summary
- As of February 7, 2025, NMRA TTM earnings before interest & taxes is -$314.55 million, with the most recent change of -$19.78 million (-6.71%) on September 30, 2024.
- Over the past year, NMRA TTM EBIT has dropped by -$41.54 million (-15.22%).
- NMRA TTM EBIT is now -1510.74% below its all-time high of -$19.53 million, reached on December 1, 2020.
Performance
NMRA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NMRA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.5% | -27.6% | -15.2% |
| 3 y3 years | -163.9% | -144.8% | -12.7% |
| 5 y5 years | - | -144.8% | -12.7% |
NMRA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.5% | at low | -188.7% | +32.8% | -138.8% | at low |
| 5 y | 5-year | -163.9% | at low | -396.3% | +57.0% | -1510.7% | at low |
| alltime | all time | -163.9% | at low | -396.3% | +57.0% | -1510.7% | at low |
Neumora Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$76.65 M(+20.1%) | -$314.55 M(+6.7%) |
| Jun 2024 | - | -$63.82 M(+6.2%) | -$294.76 M(+8.0%) |
| Mar 2024 | - | -$60.07 M(-47.3%) | -$273.00 M(+8.3%) |
| Dec 2023 | -$252.10 M(+85.5%) | -$114.00 M(+100.5%) | -$252.10 M(+49.3%) |
| Sep 2023 | - | -$56.86 M(+35.2%) | -$168.81 M(+18.4%) |
| Jun 2023 | - | -$42.06 M(+7.4%) | -$142.55 M(+8.2%) |
| Mar 2023 | - | -$39.17 M(+27.5%) | -$131.80 M(-3.0%) |
| Dec 2022 | -$135.87 M | -$30.72 M(+0.4%) | -$135.87 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$30.60 M(-2.3%) | -$131.70 M(-52.8%) |
| Jun 2022 | - | -$31.31 M(-27.6%) | -$279.23 M(+5.3%) |
| Mar 2022 | - | -$43.24 M(+62.9%) | -$265.11 M(+11.7%) |
| Dec 2021 | -$237.32 M(+148.5%) | - | - |
| Dec 2021 | - | -$26.55 M(-85.1%) | -$237.32 M(+3.0%) |
| Sep 2021 | - | -$178.13 M(+935.6%) | -$230.30 M(+341.4%) |
| Jun 2021 | - | -$17.20 M(+11.4%) | -$52.17 M(+49.2%) |
| Mar 2021 | - | -$15.45 M(-20.9%) | -$34.97 M(+79.1%) |
| Dec 2020 | -$95.52 M | -$19.53 M | -$19.53 M |
FAQ
- What is Neumora Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Neumora Therapeutics?
- What is Neumora Therapeutics annual EBIT year-on-year change?
- What is Neumora Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly EBIT year-on-year change?
- What is Neumora Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Neumora Therapeutics?
- What is Neumora Therapeutics TTM EBIT year-on-year change?
What is Neumora Therapeutics annual earnings before interest & taxes?
The current annual EBIT of NMRA is -$252.10 M
What is the all time high annual EBIT for Neumora Therapeutics?
Neumora Therapeutics all-time high annual earnings before interest & taxes is -$95.52 M
What is Neumora Therapeutics annual EBIT year-on-year change?
Over the past year, NMRA annual earnings before interest & taxes has changed by -$116.23 M (-85.54%)
What is Neumora Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of NMRA is -$76.65 M
What is the all time high quarterly EBIT for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly earnings before interest & taxes is -$15.45 M
What is Neumora Therapeutics quarterly EBIT year-on-year change?
Over the past year, NMRA quarterly earnings before interest & taxes has changed by -$16.57 M (-27.59%)
What is Neumora Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of NMRA is -$314.55 M
What is the all time high TTM EBIT for Neumora Therapeutics?
Neumora Therapeutics all-time high TTM earnings before interest & taxes is -$19.53 M
What is Neumora Therapeutics TTM EBIT year-on-year change?
Over the past year, NMRA TTM earnings before interest & taxes has changed by -$41.54 M (-15.22%)